RegenETP, Inc.

OTCPK:RGTP.Q Stock Report

Market Cap: US$1.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

RegenETP Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on RegenETP's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs Industry Growth17.04%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update31 Mar 2023

Recent past performance updates

Recent updates

Seeking Alpha • Aug 12

PolarityTE down 10% on lower-than-expected Q2 revenue

PolarityTE (NASDAQ:PTE) is trading ~10% down after the company reported lower-than-expected quarterly revenue. The company said it ceased commercial sales of SkinTE in the second calendar quarter of 2021 and sold the IBEX services business, so the Company was not engaged in any revenue generating business activity at June 30, and does not expect to generate operating revenues from any business activity for the foreseeable future. The Company had cash and cash equivalents of $20.5m
Analysis Article • Mar 08

Will PolarityTE (NASDAQ:PTE) Spend Its Cash Wisely?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article • Nov 16

Here's Why We're Watching PolarityTE's (NASDAQ:PTE) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Seeking Alpha • Jul 19

PolarityTE Is Not A DeFi Coin

PolarityTE has been dropping without an apparent catalyst since mid-June. A week before it started dropping, a new DeFi coin called Peet DeFi launched using the same symbol as PolarityTE, “PTE”. The “$PTE” cashtag on Twitter has been more or less taken over by Peet DeFi. The prices of both are dropping.
Analysis Article • Jun 04

Does PolarityTE (NASDAQ:PTE) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Feb 19

What You Need To Know About PolarityTE, Inc.'s (NASDAQ:PTE) Investor Composition

A look at the shareholders of PolarityTE, Inc. ( NASDAQ:PTE ) can tell us which group is most powerful. Institutions...

Revenue & Expenses Breakdown

How RegenETP makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:RGTP.Q Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 230-81110
31 Dec 221-81511
30 Sep 222-161812
30 Jun 223-131913
31 Mar 225-172215
31 Dec 219-302314
30 Sep 2112-322513
30 Jun 2114-382912
31 Mar 2114-473011
31 Dec 2010-433612
30 Sep 208-544813
30 Jun 206-706213
31 Mar 205-807314
31 Dec 196-928016
30 Sep 197-12811721
30 Jun 197-12511322
31 Mar 196-11610521
31 Dec 184-1119221
31 Oct 182-745119
31 Jul 180-623917
30 Apr 180-502618
31 Jan 180-14125118
31 Oct 170-13119112
31 Jul 170-12113108
30 Apr 17-1-11813105
31 Jan 17-1-880
31 Oct 160-1040
31 Jul 160-1050
30 Apr 163-950
31 Jan 164-1150
31 Oct 157-660
31 Jul 1513-1190
30 Apr 1514-13101
31 Jan 1516-13121
31 Oct 1434-16162
31 Jul 1438-15163
30 Apr 1439-16164

Quality Earnings: RGTP.Q has a high level of non-cash earnings.

Growing Profit Margin: Insufficient data to determine if RGTP.Q's profit margins have improved over the past year.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if RGTP.Q's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare RGTP.Q's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if RGTP.Q's earnings growth over the past year exceeded the Biotechs industry average.

Return on Equity

High ROE: RGTP.Q has a negative Return on Equity (0%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/18 10:53
End of Day Share Price 2025/04/16 00:00
Earnings2023/03/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

RegenETP, Inc. is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristen KluskaCantor Fitzgerald & Co.
Joshua SchimmerEvercore ISI
Swayampakula RamakanthH.C. Wainwright & Co.